News

The primary outcome measure, change from baseline on the inattention subscale of the Conners’ Adult ADHD Rating Scale-Investigator-Rated (CAARS-INV), after four weeks of treatment versus placebo was not

The additional indication is for the active immunisation against pneumonia caused by Streptococcus pneumoniae in infants and children from six weeks up to five years of age. The

Lifeline CEO Jim Holmes said the System patent completes Lifeline’s three software patents. ”We now have our Methods, Device and System patents which provide the Company with protection

The FDA said it has received more than 40 reports of burns to the skin in the years since the products have been marketed. OTC topical pain relievers

Sunshine Biopharma president and CEO Steve Slilaty said, "We have made significant recent strides in terms of research results showing the effectiveness of our lead compound against cancer

The project was based on using ERC technology licensed from Yale University to treat type 1diabetes. Shumakov Center Biomedical Research and Technology Institute head and professor Viktor Sevastianov

Eclipse develops drug candidates, such as ET101 that targets cancer stem cells (CSCs), which are the seeds at the root of cancer. Bionomics CEO and managing director Deborah

Under the agreement, Oxford Pharmascience will develop and commercialize various re-formulated statins, using the generic cholesterol-lowering drugs, atorvastatin and simvastatin. In addition, Oxford has established the feasibility of

The migraine treatment drug candidate, MSRX-202, leverages MonoSol PharmFilm technology in a combination product that includes rizatriptan for the treatment of migraine pain and ondansetron for the treatment